Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Verifiedinfo

Haemato-Onkologie Hamburg - Prof. Laack und Partner

Germany Lehmweg 7, 20251 Hamburg, Germany

  • 2 trials recruiting
  • Non-small cell lung cancer · Non-small cell lung cancer stage III · Non-small cell lung cancer stage II
  • Adult patients

About Specializations

Haemato-Onkologie Hamburg - Prof. Laack und Partner in Hamburg, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage III, Non-small cell lung cancer stage II, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms

The Haemato‑Onkologie Hamburg – Prof. Laack und Partner concentrates on cancer research, targeting TROP2‑positive advanced or metastatic non‑squamous non‑small cell lung cancer. Ongoing studies evaluate the safety and efficacy of the antibody‑drug conjugate datopotamab deruxtecan versus standard chemotherapy, with the goal of improving patient outcomes such as progression‑free and overall survival.

  • Evaluation of a novel antibody‑drug conjugate for lung cancer
  • Direct comparison with standard docetaxel therapy
  • Measurement of progression‑free survival and overall survival benefits

With two investigators working at the Hamburg location, the site demonstrates a focused commitment to expanding therapeutic options for patients without actionable genomic alterations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Lehmweg 720251 HamburgGermany
Open in maps ↗
Recruiting now
2 trials
Conditions studied
7
Partner status
Verified

More sites in HamburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Non-small cell lung cancer

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Non-small cell lung cancer

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB

Non-small cell lung cancer stage III+5

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ociperlimab
  • Sponsor:Beigene Ltd.

Non-small cell lung cancer+2

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Non-small cell lung cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Non-small cell lung cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.